---
title: "Pre-market hot trades in US stocks: Marsh & Mclennan pre-market down 7.06%; CVD Equipment pre-market down 7.04%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286893831.md"
description: "Marsh & Mclennan pre-market down 7.06%; CVD Equipment pre-market down 7.04%; Amesite pre-market up 229.47%; Meitu Technology pre-market up 99.54%; MetaVia pre-market up 71.17%"
datetime: "2026-05-19T10:22:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286893831.md)
  - [en](https://longbridge.com/en/news/286893831.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286893831.md)
---

# Pre-market hot trades in US stocks: Marsh & Mclennan pre-market down 7.06%; CVD Equipment pre-market down 7.04%

**Pre-market Hot Trades in US Stocks**

Marsh & Mclennan, down 7.06% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

CVD Equipment, down 7.04% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in Pre-market US Stocks**

Amesite up 229.47% in pre-market. Based on recent key news:

1.  On May 19, Amesite secured a new corporate client involving approximately 2,700 patients, marking its largest deployment to date, which significantly boosted the stock price in pre-market trading. This client will use NurseMagic AI documentation to streamline workflows, expected to significantly reduce the administrative burden on nurses weekly.
    
2.  On May 19, Amesite's CEO Ann Marie Sastry purchased 174,216 shares of common stock at a price of $1.44 per share, increasing her direct holdings to 1,049,647 shares. This insider purchase has bolstered market confidence in the company's future development.
    
3.  On May 19, Amesite reported revenue growth to $285,678, with net losses narrowing to $2.05 million. Despite successfully raising $2.6 million in funding and strategically shifting towards medical AI solutions, there remain significant doubts about its ability to continue as a going concern. The market potential for AI medical solutions is enormous, with evident capital inflow.
    

Meitu Technology, up 99.54% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

MetaVia up 71.17% in pre-market. MetaVia up 71.17% in pre-market. No significant news recently; trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news

### Related Stocks

- [MRSH.US](https://longbridge.com/en/quote/MRSH.US.md)
- [CVV.US](https://longbridge.com/en/quote/CVV.US.md)
- [AMST.US](https://longbridge.com/en/quote/AMST.US.md)
- [WNW.US](https://longbridge.com/en/quote/WNW.US.md)
- [MTVA.US](https://longbridge.com/en/quote/MTVA.US.md)

## Related News & Research

- [CVD Equipment Corporation Reports First Quarter 2026 Results | CVV Stock News](https://longbridge.com/en/news/286458836.md)
- [Marsh & McLennan Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/286569526.md)
- [Atria Investments Inc Has $13.47 Million Position in Marsh & McLennan Companies, Inc. $MRSH](https://longbridge.com/en/news/286523542.md)
- [Singapore Leads Emerging Race to Become World’s First «Trusted AI Financial Hub»](https://longbridge.com/en/news/287063092.md)
- [06:07 ETStandardC Launches AI Platform for Financial Institutions, Where Customer PII Is Never Shared With AI Models (Patent Pending)](https://longbridge.com/en/news/286892045.md)